SCHEMBL7384196

SCHEMBL7384196

COC(=O)CO[CH]c1ccccc1

nearest known ligand 0.47

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
POLB P06746 3/20 0.43
ALDH1A1 P00352 4/20 0.42
MEN1 O00255 3/20 0.42
KMT2A Q03164 3/20 0.42
KDM4E B2RXH2 2/20 0.42
MAPT P10636 1/20 0.42
AKT1 P31749 1/20 0.41
PTGS2 P35354 1/20 0.41
RECQL P46063 1/20 0.40
TSHR P16473 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
LMNA P02545 1/20 0.39
NPC1 O15118 1/20 0.39
RAB9A P51151 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5727816 0.81 PTPN1 (0.38) POLBALDH1A1MEN1KMT2AKDM4E
SCHEMBL3300954 0.80 ALOX15 (0.48) POLBALDH1A1MEN1KMT2AMAPT
SCHEMBL27087365 0.79 AKT1 (0.46) POLBALDH1A1MEN1KMT2AKDM4E
SCHEMBL12493341 0.78 TSHR (0.47) ALDH1A1MEN1KMT2AKDM4ETSHR
SCHEMBL5547366 0.77 KDM4E (0.44) ALDH1A1MEN1KMT2AKDM4EMAPT
SCHEMBL5410674 0.74 TRPA1 (0.39) ALDH1A1MEN1KMT2ATSHR
Benzophenone SCHEMBL28414451 0.74 ALDH1A1 (0.47) ALDH1A1MEN1KMT2AKDM4EMAPT
SCHEMBL290049 0.73 POLB (0.46) POLBALDH1A1MEN1KMT2AKDM4E
SCHEMBL2363130 0.73 GPR174 (0.38) ALDH1A1MEN1KMT2AMAPTRECQL
SCHEMBL27303351 0.73 MEN1 (0.62) POLBALDH1A1MEN1KMT2AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0994896-A1 SULFONYLATED DIPEPTIDE COMPOUNDS WHICH INHIBIT LEUKOCYTE ADHESION MEDIATED BY VLA-4 Elan Pharmaceuticals, Inc. (US) 2000-04-26 EP claimed
WO-1999006437-A1 SULFONYLATED DIPEPTIDE COMPOUNDS WHICH INHIBIT LEUKOCYTE ADHESION MEDIATED BY VLA-4 ELAN PHARMACEUTICALS INC. (US) 1999-02-11 WO claimed